GlaxoSmithKline Presents Innovative Neuroscience Pipeline

...laxis planned - New phase II studies in neuropathic pain announced -- Four CNS products with potential to be launched or approved in 2008: - trexima potential "new gold standard" for migraine; - Lamictal XR new once daily treatment for epilepsy; - Lunivia, a successful treatment for insomni...

Trexima in Medical Technology

Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMA

... trexima provided superior sustained pain-free results comp...ed to placebo and its individual components." trexima is the proposed brand name for a single tablet con...3,413 patients were randomized to receive a single trexima tablet, a single tablet containing sumatriptan 85 ...

Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks

... These data are significant because they show that trexima produced consistent pain-free results across multi...ts (80 percent) treated three of four attacks with trexima and the remaining attack with placebo; the remaini... all four attacks with Trexima. In both studies, trexima produced a consistent response from attack to atta...

Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms

...ients using the investigational migraine treatment trexima early in their migraine attacks were pain free at ...ltiple attacks. In both studies, patients taking trexima reported a significantly lower incidence of tradit...ours. -- The approximate difference between trexima and placebo at two hours for each symptom ...

Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks

... Nearly Twice as Many Patients Taking trexima were Migraine Free Compared to Placebo CHICAGO, J...migraine attacks. Patients in four groups received trexima in three of four attacks and placebo in the remaining attack. Patients in the fifth group received trexima for all four attacks. In each study, approximate...